Lightship

Lightship is a United States-based startup that was founded in 2018 with a mission to redefine clinical trials and provide hope for all. The company's slogan, "Redefining clinical trials. Providing hope for all," encapsulates its commitment to improving health equity globally. Lightship aims to make clinical research more accessible and offer choice, believing that learning if treatments are safe and effective for those in need requires inclusive and innovative approaches. The company's innovative approach leverages digital health, technology, and remote care, fused with high-quality clinical research, to transform clinical trials. Lightship designs its clinical trials from the outset to prioritize accessibility for patients and caregivers. By utilizing inclusive technology, flexible visit types, and a dedication to quality, Lightship aims to create an amazing experience for participants while developing programs to bring potentially life-saving therapies into the world. In its latest funding round, Lightship secured a significant $16.51M Series C investment on 12 February 2024, highlighting the confidence of investors in the company's vision and capabilities. Although the specific investors for this round are not disclosed, this funding underscores the industry's recognition of Lightship's potential to make a meaningful impact in the healthcare sector. As the company continues to redefine clinical trials and prioritize health equity, it positions itself as an innovative player in the Health Care industry, with the potential to shape the future of clinical research on a global scale.